Prolactin has a pathogenic role in systemic lupus erythematosus - PubMed (original) (raw)
Prolactin has a pathogenic role in systemic lupus erythematosus
Luis J Jara et al. Immunol Res. 2017 Apr.
Abstract
Prolactin, a 23-kDa peptide hormone, is produced by the anterior pituitary gland and extrapituitary sites including the immune cells. Prolactin (PRL) participates in innate and adaptive immune response. PRL stimulates the immune cells by binding to receptor (PRL-R). Binding of PRL to its receptor activates the Janus kinase-signal transducer (JAK-STAT). Activation of these cascades results in endpoints such as immunoestimulator and immunosupressor action. Prolactin belongs to the network of immune-neuroendocrine interaction. Hyperprolactinemia has been found in patients with systemic lupus erythematosus (SLE), and new evidence has confirmed a significant correlation between serum PRL levels and disease activity. PRL participates in activation of SLE during pregnancy and in pathogenesis of lupus nephritis, neuropsychiatric, serosal, hematologic, articular, and cutaneous involvement. Hyperprolactinemia was associated with increase IgG concentrations, anti-DNA antibodies, immune complex, glomerulonephritis, and accelerated mortality in murine lupus. Bromocriptine, a dopamine analog that suppresses PRL secretion, was associated with decreased lupus activity, prolonged lifespan, and restoration of immune competence in experimental model. In clinical trials, bromocriptine and derivative drugs showed beneficial therapeutic effect in treating human lupus, including pregnancy. Taken together, clinical and experimental results leave little doubt that PRL indeed contributes to the pathogenesis and clinical expression of SLE.
Keywords: Adaptive immune response; Bromocriptine; Innate immune response; Prolactin; Systemic lupus erythematosus.
Comment in
- Prolactin and systemic lupus erythematosus.
Joob B, Wiwanitkit V. Joob B, et al. Immunol Res. 2017 Aug;65(4):975. doi: 10.1007/s12026-017-8916-0. Immunol Res. 2017. PMID: 28324219 No abstract available.
Similar articles
- Prolactin in human systemic lupus erythematosus.
Jara LJ, Vera-Lastra O, Miranda JM, Alcala M, Alvarez-Nemegyei J. Jara LJ, et al. Lupus. 2001;10(10):748-56. doi: 10.1191/096120301717164994. Lupus. 2001. PMID: 11721702 Review. - [Prolactin in connective tissue diseases].
Parada-Turska J, Targońska-Stepniak B, Majdan M. Parada-Turska J, et al. Postepy Hig Med Dosw (Online). 2006;60:278-85. Postepy Hig Med Dosw (Online). 2006. PMID: 16715039 Review. Polish. - Prolactin as a modulator of B cell function: implications for SLE.
Peeva E, Venkatesh J, Michael D, Diamond B. Peeva E, et al. Biomed Pharmacother. 2004 Jun;58(5):310-9. doi: 10.1016/j.biopha.2004.04.007. Biomed Pharmacother. 2004. PMID: 15194167 Review. - Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia.
Leaños A, Pascoe D, Fraga A, Blanco-Favela F. Leaños A, et al. Lupus. 1998;7(6):398-403. doi: 10.1191/096120398678920280. Lupus. 1998. PMID: 9736323 - Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
Pacilio M, Migliaresi S, Meli R, Ambrosone L, Bigliardo B, Di Carlo R. Pacilio M, et al. J Rheumatol. 2001 Oct;28(10):2216-21. J Rheumatol. 2001. PMID: 11669159
Cited by
- [Pathogenesis of systemic lupus erythematosus].
Finzel S, Schaffer S, Rizzi M, Voll RE. Finzel S, et al. Z Rheumatol. 2018 Nov;77(9):789-798. doi: 10.1007/s00393-018-0541-3. Z Rheumatol. 2018. PMID: 30291433 Review. German. - Editorial: Cutting edge in systemic lupus erythematosus.
D'Cruz DP, Kuhn A. D'Cruz DP, et al. Immunol Res. 2017 Apr;65(2):429-431. doi: 10.1007/s12026-017-8910-6. Immunol Res. 2017. PMID: 28303447 Free PMC article. No abstract available. - Prolactin and systemic lupus erythematosus.
Joob B, Wiwanitkit V. Joob B, et al. Immunol Res. 2017 Aug;65(4):975. doi: 10.1007/s12026-017-8916-0. Immunol Res. 2017. PMID: 28324219 No abstract available. - Sex and gender influence on immunity and autoimmunity.
Lahita RG. Lahita RG. Front Immunol. 2023 May 26;14:1142723. doi: 10.3389/fimmu.2023.1142723. eCollection 2023. Front Immunol. 2023. PMID: 37304263 Free PMC article. Review. - Identification of periductal mastitis and granulomatous lobular mastitis: a literature review.
Jiao Y, Chang K, Jiang Y, Zhang J. Jiao Y, et al. Ann Transl Med. 2023 Feb 15;11(3):158. doi: 10.21037/atm-22-6473. Epub 2023 Feb 3. Ann Transl Med. 2023. PMID: 36846004 Free PMC article. Review.
References
- Am J Reprod Immunol. 2011 Apr;65(4):433-7 - PubMed
- Clin Exp Rheumatol. 2010 Nov-Dec;28(6):866-72 - PubMed
- Lupus. 2001;10(10):762-8 - PubMed
- J Inflamm (Lond). 2015 Feb 18;12:13 - PubMed
- Acta Physiol (Oxf). 2016 Jan;216(1):42-89 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical